SynthesisBMC psychiatry2025
The impact of visual impairment and comorbid mental health disorders on daily functioning: a systematic literature review.
Synthesis in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study was to systematically assess and discuss literature on the impact of visual impairment (VI) in combination with specific mental health disorders (MHDs), i.e. personality disorders (including antisocial, borderline and dependent personality disorder), autism spectrum disorder (ASD), obsessive-compulsive disorder and psychotic disorders, on daily functioning.
methodsA systematic review was performed following the PRISMA-statement. The databases PubMed, Embase, CINAHL, PsycINFO, Cochrane library, and Web of Science were searched for relevant publications up to December 20th, 2024. Quality assessment was conducted following the criteria of the PHO MetaQAT. Thematic content analysis was performed to indicate the impact of VI and the chosen MHDs on daily functioning.
resultsTwenty-two relevant publications were found. Twenty-one publications described the impact of the combination of VI and ASD and sometimes additional disorders, and focused on children, predominantly in school settings. One publication addressed VI and psychosis. The impact on daily functioning was described according to age and MHD, and categorized by five main themes: (1) psychological functioning, (2) social functioning, (3) physical functioning, (4) school performance, and (5) parental and clinical support. One publication had ‘sufficient’ and ‘good’ ratings on validity, while all others had at least one ‘insufficient’ or ‘unclear’ rating.
conclusionsA limited number of publications on the combined impact of VI and MHDs on daily functioning were found. Publications primarily focused on VI and ASD in children. Uncertainty about the impact remains due to a lack of high-quality publications. The gap in evidence calls for future research to address the challenges in supporting people with VI and MHDs. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.